Total Funding
87
72
Total FundingPre-Seed raised
Growth Score 87 in past quarter
-4 pts
Heat Score 72 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
126042
Incipiam Pharma focuses on developing innovative treatments for metabolic diseases by targeting energy expenditure.
About the Company
Incipiam Pharma focuses on developing innovative treatments for metabolic diseases by targeting energy expenditure. Incipiam Pharma is focused on developing treatments that target energy expenditure, moving beyond the common approach of only reducing energy intake. Incipiam Pharma believes this focus will lead to innovative and transformative
treatments for obesity and diabetes.